Your browser doesn't support javascript.
loading
Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
Harada, Kazuto; Wu, Carol C; Wang, Xuemei; Mizrak Kaya, Dilsa; Amlashi, Fatemeh G; Iwatsuki, Masaaki; Blum Murphy, Mariela A; Maru, Dipen M; Weston, Brian; Lee, Jeffrey H; Rogers, Jane E; Thomas, Irene; Shanbhag, Namita; Bhutani, Manoop S; Hofstetter, Wayne L; Nguyen, Quynh-Nhu; Ajani, Jaffer A.
Afiliação
  • Harada K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wu CC; Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
  • Wang X; Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Mizrak Kaya D; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Amlashi FG; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Iwatsuki M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Blum Murphy MA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Maru DM; Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
  • Weston B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Lee JH; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Rogers JE; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Thomas I; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Shanbhag N; Department of Pharmacy Clinical Programs, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Bhutani MS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hofstetter WL; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Nguyen QN; Department of Gastroenterology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ajani JA; Department of Thoracic and Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Ann Surg ; 272(2): 311-318, 2020 08.
Article em En | MEDLINE | ID: mdl-32675544
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Quimiorradioterapia / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: America do norte Idioma: En Revista: Ann Surg Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Quimiorradioterapia / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged80 País/Região como assunto: America do norte Idioma: En Revista: Ann Surg Ano de publicação: 2020 Tipo de documento: Article